AbbVie has struck a new drug pricing agreement with the White House that aligns with the administration’s most-favored-nation pricing initiative. Under the deal, the company will lower prices on select medicines for Medicaid and expand direct-to-patient offerings through the TrumpRx platform, while committing to $100 billion in U.S. research, development and capital investment over the next decade.
Career Expert Tips for Handling “Overqualified” Questions in Interviews
Being labeled “overqualified” can feel like a setback, but career experts say it’s often a soft rejection rather than a reflection of your ability. The key is to own your story—explain why you’re genuinely interested in the role, how your experience aligns with the company’s needs, and that you see long-term value in the position. Experts emphasize reframing your background as an asset and addressing potential employer concerns about fit, commitment, and career goals.
FDA Approves First Oral Wegovy Weight-Loss Pill
The U.S. Food and Drug Administration has approved a daily oral version of the popular weight-loss drug Wegovy, marking a major milestone in obesity treatment. This first-of-its-kind GLP-1 weight-loss pill from Novo Nordisk contains the same active ingredient, semaglutide, found in the injectable Wegovy and Ozempic, and is expected to expand access to those who prefer a pill over injections.
FDA Grants First-Line Approval for Enhertu Combination in HER2-Positive Breast Cancer
The U.S. Food and Drug Administration has approved AstraZeneca and Daiichi Sankyo’s antibody-drug conjugate Enhertu (fam-trastuzumab deruxtecan) in combination with Roche’s Perjeta as a first-line treatment for adults with unresectable or metastatic HER2-positive breast cancer confirmed by an FDA-approved test.
This new indication is supported by positive results from the Phase III DESTINY-Breast09 trial, which showed the Enhertu-Perjeta regimen significantly improved median progression-free survival (40.7 vs. 26.9 months) and reduced the risk of disease progression or death compared with the previous standard of care (taxane, trastuzumab and pertuzumab).
The approval expands Enhertu’s use beyond later-line settings, where it had previously earned FDA clearance, and could establish the combination as a new frontline standard of care in this aggressive oncology segment
Click here to read the entire article.
Do not share sensitive information with ChatGPT and other AI chatbots
Experts are warning users not to share sensitive information with ChatGPT and other AI chatbots because the data you type can be stored, analyzed, and used to improve models — and may not remain private. The key categories of information you should avoid sharing include personally identifiable details (name, address, IDs), intimate personal life details, medical and health information, confidential work or proprietary business data, and financial information like bank or credit card details.
UCB Announces Plan to Seek Regulatory Approval for Fintepla in CDKL5 Deficiency Disorder Following Positive Phase 3 Results
UCB announced that it will move forward with regulatory submissions for Fintepla® (fenfluramine) as a treatment for seizures associated with CDKL5 Deficiency Disorder (CDD), following highly positive results from its Phase 3 clinical trial. This represents a potential third indication for Fintepla, which is already approved for Dravet syndrome and Lennox-Gastaut syndrome.
From Skill Gaps to Growth Engines: How Smart Training (and Language Learning) Transforms Teams and Businesses
Gen Z Is Rewriting Office Culture
As Gen Z returns to the office in growing numbers, they’re not just filling the physical space — they’re transforming it. According to a CNBC article, this generation is leaning into authenticity, mental health, and digital fluency, bringing new energy to work environments older generations may no longer frequent. From candid check-ins on well-being, to dressing casually and speaking in their own voice, to fully embracing AI tools as collaborators — Gen Z is reshaping corporate norms on its own terms.
Regeneron to convert former magazine factory into drug plant
Hiring? Don’t just ask “Tell me about a time you did X.”
The No. 1 trait workers need for success
What’s the top trait that separates stand-out employees in today’s workplace? According to Cristina Mancini, CEO of nonprofit Black Girls Code, it isn’t simply technical ability or charisma — it’s curiosity. In her view, the ability to manage your emotions, understand others, and build strong relationships is the game-changer for success.
The Bandish Group has been recognized as the Best Boutique Life Sciences Executive Search Firm – USA by Corporate America Today
Beyond the Degree: How Practical Learning Paths Are Redefining Growth
Formal education once stood as the main gatekeeper to professional success. Today, flexible, non-degree programs—executive coaching, public speaking workshops, and language learning—offer equally powerful routes to growth. These options are leaner, more adaptable, and often more transformative in developing real-world competence and confidence.
Roche nabs FDA clearance
Roche has received FDA clearance for its Alzheimer’s blook biomarker blood test. Trontinemab, currently in phase 3 trials, was developed in collaboration with Eli Lilly and is designed to help assess early signs or Alzheimer’s as well as other causes on cognitive decline in patients over 55 years old.
Successful employees have 6 things in common
The Bandish Group named 'Best Biotech & Pharma Executive Search Firm 2025'
Thank you to our clients for your continued trust. We are proud to announce that The Bandish Group has been recognized as the “Best Biotech & Pharma Executive Search Firm 2025” at the Global 100 Awards. This recognition reflects our commitment to excellence in serving the biotech and pharmaceutical sectors.
Smarter Pharmaceutical Warehousing Starts With Sharper Investments
Warehouse operations in the pharmaceutical sector are no longer background infrastructure. They’re active levers for efficiency, compliance, and product integrity. With regulatory pressures mounting and logistics complexity rising, warehouses have become critical control points, not just for inventory, but for reputation. That means companies can’t afford to treat upgrades as piecemeal patches. They need targeted investment in systems, design, people, and architecture. This article breaks down the most high-impact areas where pharmaceutical companies should be putting real money, not just attention.
Navigating Your Next Move - Panel and Networking Event
Are you thinking about making a career change or exploring your next professional move? Whether you're pursuing a new role by choice or navigating a transition, this Women in Bio interactive event in Philadelphia is here to equip you with the tools and confidence to take that next step. Learn more here: Navigating Your Next Move
Think twice about using these 5 phrases in emails
Email and other written communication lack the context of tone, facial expressions, and body language. Even when you intend to be polite and professional, passive-aggressive phrases can unintentionally slip in—whether you're updating your boss, sending deliverables to a client, or collaborating with coworkers.